Lyka Labs (BOM:500259) Days Sales Outstanding : 88.70 (As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Lyka Labs Days Sales Outstanding?

Lyka Labs's average Accounts Receivable for the three months ended in Mar. 2024 was ₹270 Mil. Lyka Labs's Revenue for the three months ended in Mar. 2024 was ₹278 Mil. Hence, Lyka Labs's Days Sales Outstanding for the three months ended in Mar. 2024 was 88.70.

The historical rank and industry rank for Lyka Labs's Days Sales Outstanding or its related term are showing as below:

BOM:500259' s Days Sales Outstanding Range Over the Past 10 Years
Min: 26.96 Med: 88.56 Max: 217.14
Current: 83.7

During the past 13 years, Lyka Labs's highest Days Sales Outstanding was 217.14. The lowest was 26.96. And the median was 88.56.

BOM:500259's Days Sales Outstanding is ranked worse than
57.79% of 886 companies
in the Biotechnology industry
Industry Median: 72.34 vs BOM:500259: 83.70

Lyka Labs's Days Sales Outstanding increased from Mar. 2023 (82.58) to Mar. 2024 (88.70).

Lyka Labs Days Sales Outstanding Historical Data

The historical data trend for Lyka Labs's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lyka Labs Days Sales Outstanding Chart

Lyka Labs Annual Data

Trend

Jun14

Jun15

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

74.57

45.46

26.96

75.65

77.33

Lyka Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															82.58	80.28	95.79	82.33	88.70

Competitive Comparison of Lyka Labs's Days Sales Outstanding

For the Biotechnology subindustry, Lyka Labs's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lyka Labs's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lyka Labs's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Lyka Labs's Days Sales Outstanding falls into.

Lyka Labs Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Lyka Labs's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (201.257	+	269.925)	/	2 )	/	1111.946	*	365
=	235.591					/	1111.946	*	365
=	77.33

Lyka Labs's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	269.925)	/	1 )	/	277.673	*	365 / 4
=	269.925					/	277.673	*	365 / 4
=	88.70

Lyka Labs (BOM:500259) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Lyka Labs Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Lyka Labs's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Lyka Labs (BOM:500259) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lyka Labs Ltd (BOM:500259) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

LYKALABS:India

Address

30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Grant Road (West), Mumbai, MH, IND, 400036

Website

http://www.lykalabs.com

Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment viz. pharmaceuticals. The Company has presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.

Lyka Labs (BOM:500259) Headlines

No Headlines